- Home
- DRUG vs SJT Comparison
DRUG vs SJT Comparison
Compare DRUG & SJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- SJT
- Stock Information
- Founded
- DRUG 2019
- SJT 1980
- Country
- DRUG United States
- SJT United States
- Employees
- DRUG N/A
- SJT N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- SJT Oil & Gas Production
- Sector
- DRUG Health Care
- SJT Energy
- Exchange
- DRUG Nasdaq
- SJT Nasdaq
- Market Cap
- DRUG 253.2M
- SJT 227.0M
- IPO Year
- DRUG N/A
- SJT N/A
- Fundamental
- Price
- DRUG $36.06
- SJT $5.19
- Analyst Decision
- DRUG Strong Buy
- SJT
- Analyst Count
- DRUG 4
- SJT 0
- Target Price
- DRUG $84.33
- SJT N/A
- AVG Volume (30 Days)
- DRUG 50.7K
- SJT 340.0K
- Earning Date
- DRUG 02-14-2025
- SJT 03-31-2025
- Dividend Yield
- DRUG N/A
- SJT 1.24%
- EPS Growth
- DRUG N/A
- SJT N/A
- EPS
- DRUG N/A
- SJT 0.19
- Revenue
- DRUG N/A
- SJT $11,031,594.00
- Revenue This Year
- DRUG N/A
- SJT N/A
- Revenue Next Year
- DRUG N/A
- SJT N/A
- P/E Ratio
- DRUG N/A
- SJT $27.68
- Revenue Growth
- DRUG N/A
- SJT N/A
- 52 Week Low
- DRUG $0.93
- SJT $3.21
- 52 Week High
- DRUG $79.02
- SJT $5.76
- Technical
- Relative Strength Index (RSI)
- DRUG 49.87
- SJT 60.02
- Support Level
- DRUG $31.55
- SJT $5.01
- Resistance Level
- DRUG $36.25
- SJT $5.29
- Average True Range (ATR)
- DRUG 2.74
- SJT 0.24
- MACD
- DRUG 0.01
- SJT 0.00
- Stochastic Oscillator
- DRUG 66.15
- SJT 83.06
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About SJT San Juan Basin Royalty Trust
San Juan Basin Royalty Trust is an energy sector royalty trust in the United States. It owns approximately 75% net profit interest in a large number of natural gas properties in the San Juan Basin of New Mexico. About 98% of the royalties San Juan collects come from natural gas, with the balance coming from oil.